Cardio Diagnostics Holdings Inc is a medical technology company focused on developing and commercializing epigenetics-based clinical tests for cardiovascular diseases and associated comorbidities by leveraging its Artificial Intelligence (AI)-driven Multi-Omics Engine. The company has developed two clinical products: Epi+Gen CHD and PrecisionCHD, epigenetics-based clinical blood tests capable of assessing risk for a coronary heart disease (CHD) event, including heart attacks. Additionally, its portfolio includes HeartRisk, a cardiovascular disease risk intelligence platform, and CardioInnovate360, a research-use-only solution launched to support the discovery, development, and validation of novel biopharmaceuticals for the assessment and management of cardiovascular diseases.
Show more...
FAQ
Cardio Diagnostics 今天的股價是多少?▼
CDIO 目前價格為 $1.99 USD,過去 24 小時上漲了 +4.19%。在圖表上更密切關注 Cardio Diagnostics 股價表現。
Cardio Diagnostics 的股票代號是什麼?▼
根據交易所不同,股票代號可能會有所差異。例如,在 XNAS 交易所,Cardio Diagnostics 的股票以代號 CDIO 進行交易。
Cardio Diagnostics 的股價在上漲嗎?▼
CDIO 股票較上週下跌 -7.87%,本月上漲 +15.7%,過去一年 Cardio Diagnostics 下跌 -45.78%。
Cardio Diagnostics 的市值是多少?▼
今天 Cardio Diagnostics 的市值為 5.89M
Cardio Diagnostics 下一次財報日期是什麼時候?▼
Cardio Diagnostics 將於 December 02, 2026 公布下一次財報。
Cardio Diagnostics 去年的營收是多少?▼
Cardio Diagnostics 去年的營收為 15,000USD。
Cardio Diagnostics 去年的淨利是多少?▼
CDIO 去年的淨收益為 -6.5MUSD。
Cardio Diagnostics 有多少名員工?▼
截至 August 19, 2026,公司共有 17 名員工。
Cardio Diagnostics 位於哪個產業?▼
Cardio Diagnostics從事於Health & Wellness產業。
Cardio Diagnostics 何時完成拆股?▼
Cardio Diagnostics 上次拆股發生於 May 13, 2025,比例為 1:30。
Cardio Diagnostics 的總部在哪裡?▼
Cardio Diagnostics 的總部位於 美國 的 CHICAGO。